Author

O. K. Okamoto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Marins dos Santos· 1 shared C. Ishihama Suzuki· 1 shared C. Kaid· 1 shared C. M. Watanabe· 1 shared D. Wald· 1 shared F. P. S. Santos· 1 shared G. Lee· 1 shared J. A. P. d. Godoy· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Marins dos Santos

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Induction of expansion of ex vivo NK cells using a new feeder cell built in Brazil. An extended flow cytometry evaluation of K562.mbIL21.4BBL

C. M. Watanabe, C. Ishihama Suzuki, A. Marins dos Santos, T. P. A. Aloia, G. Lee, D. Wald, O. K. Okamoto, J. T. C. d. Azevedo, J. A. P. d. Godoy, F. P. S. Santos, R. Weinlich, L. N. Kerbauy, J. M. Kutner, R. d. M. A. Paiva, N. Hamerschlak

This paper develops a Brazilian feeder cell, K562.Clone1, which expands NK cells ex vivo more than 100-fold while preserving their antitumor activity.

bioRxiv · Feb 23, 2024 · PreprintCancer Biology

Integrative transcriptomic and proteomic meta-analysis of Zika viral infection reveals potential mechanisms for oncolytic therapy in neuroblastoma

M. Sherwood, Y. Zhou, Y. Sui, Y. Wang, P. Skipp, C. Kaid, J. Gray, O. K. Okamoto, R. M. Ewing

This study identifies molecular mechanisms of Zika virus-induced oncolysis in neuroblastoma and highlights a promising oncolytic virotherapy candidate.

bioRxiv · Nov 14, 2022 · PreprintCancer Biology